These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 35299902

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effect of Nigella sativa oil- and wheat germ oil-loaded metal organic frameworks on chronic murine toxoplasmosis.
    Mohammad OS, El Naggar HM, Abdelmaksoud HF, Barakat AM, Abdelhameed RM, Shehata MAS.
    Acta Trop; 2023 Mar; 239():106823. PubMed ID: 36608751
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Nanoemulsion of Spiramycin against Tachyzoites of Toxoplasma gondii, RH Strain: Preparation, Toxicology, and Efficacy Studies.
    Hashemi-Hafshejani S, Amani A, Jafarpour Azami S, Keshavarz Valian H, Mohebali M, Salimi M, Lafmejan Pour HH, Shojaee S.
    Iran J Public Health; 2023 Jul; 52(7):1495-1503. PubMed ID: 37593518
    [Abstract] [Full Text] [Related]

  • 26. Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis.
    El-Zawawy LA, El-Said D, Mossallam SF, Ramadan HS, Younis SS.
    Exp Parasitol; 2015 Feb; 149():54-64. PubMed ID: 25499511
    [Abstract] [Full Text] [Related]

  • 27. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG, Shepard RM, Remington JS.
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [Abstract] [Full Text] [Related]

  • 28. [In vitro effect of (+)-usnic acid on Toxoplasma gondii tachyzoites].
    Wei LL, Cheng YB, Si KW, Gu N, Li XQ, Li C, Yuan YK.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec 30; 26(6):438-41. PubMed ID: 19288918
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Studies on the therapeutics of experimental toxoplasmosis. I. Effect of acetylspiramycin and spiramycin on the intracardiac Toxoplasma multiplication in mice infected with Toxoplasma gondii (author's transl)].
    Espinas FM, Odakura Y, Suzuki N, Sasaki H.
    Jpn J Antibiot; 1981 Aug 30; 34(8):1141-7. PubMed ID: 7321193
    [Abstract] [Full Text] [Related]

  • 31. Ginger Is a Potential Therapeutic for Chronic Toxoplasmosis.
    El-Kady AM, Al-Megrin WAI, Abdel-Rahman IAM, Sayed E, Alshehri EA, Wakid MH, Baakdah FM, Mohamed K, Elshazly H, Alobaid HM, Qahl SH, Elshabrawy HA, Younis SS.
    Pathogens; 2022 Jul 15; 11(7):. PubMed ID: 35890042
    [Abstract] [Full Text] [Related]

  • 32. Effects of Lactobacilli acidophilus and/or spiramycin as an adjunct in toxoplasmosis infection challenged with diabetes.
    El Saftawy EA, Turkistani SA, Alghabban HM, Albadawi EA, Ibrahim BE, Morsy S, Farag MF, Al Hariry NS, Shash RY, Elkazaz A, Amin NM.
    Food Waterborne Parasitol; 2023 Sep 15; 32():e00201. PubMed ID: 37719029
    [Abstract] [Full Text] [Related]

  • 33. Biogenic selenium nanoparticles: trace element with promising anti-toxoplasma effect.
    Arafa FM, Mogahed NMFH, Eltarahony MM, Diab RG.
    Pathog Glob Health; 2023 Oct 15; 117(7):639-654. PubMed ID: 36871204
    [Abstract] [Full Text] [Related]

  • 34. Chitosan and silver nanoparticles: promising anti-toxoplasma agents.
    Gaafar MR, Mady RF, Diab RG, Shalaby TI.
    Exp Parasitol; 2014 Aug 15; 143():30-8. PubMed ID: 24852215
    [Abstract] [Full Text] [Related]

  • 35. Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection.
    Franco PS, Gomes AO, Barbosa BF, Angeloni MB, Silva NM, Teixeira-Carvalho A, Martins-Filho OA, Silva DA, Mineo JR, Ferro EA.
    Placenta; 2011 Nov 15; 32(11):838-44. PubMed ID: 21908042
    [Abstract] [Full Text] [Related]

  • 36. Promising In Vitro Anti-Toxoplasma gondii Effects of Commercial Chitosan.
    Esboei BR, Keighobadi M, Hezarjaribi HZ, Fakhar M, Daryani A, Chabra A, Soosaraei M, Yalveh R.
    Infect Disord Drug Targets; 2021 Nov 15; 21(1):151-155. PubMed ID: 32389115
    [Abstract] [Full Text] [Related]

  • 37. Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies.
    El Zawawy LA.
    J Egypt Soc Parasitol; 2008 Apr 15; 38(1):185-201. PubMed ID: 19143130
    [Abstract] [Full Text] [Related]

  • 38. microRNA-155 Expression and Butyrylcholinesterase Activity in the Liver Tissue of Mice Infected with Toxoplasma gondii (Avirulent and Virulent Strains).
    El-Sayad M, Abdel Rahman M, Hussein N, Abdel Aziz R, El-Taweel HA, Abd El-Latif N.
    Acta Parasitol; 2021 Dec 15; 66(4):1167-1176. PubMed ID: 33840057
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
    Darvishi MM, Moazeni M, Alizadeh M, Abedi M, Tamaddon AM.
    Parasitol Res; 2020 Dec 15; 119(12):4233-4241. PubMed ID: 32996050
    [Abstract] [Full Text] [Related]

  • 40. Synthesis, characterization, and antiparasitic effects of zinc oxide nanoparticles-eugenol nanosuspension against Toxoplasma gondii infection.
    Cheraghipour K, Khudair Khalaf A, Moradpour K, Zivdari M, Beiranvand M, Shakib P, Mahmoudvand H, Marzban A.
    Heliyon; 2023 Aug 15; 9(8):e19295. PubMed ID: 37654466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.